For more than a decade, the International Myeloma Foundation has attended the American Society of Hematology (ASH) annual meeting, an exciting convergence of more than 30,000 health-care professionals from around the world. This year’s ASH annual meeting took place in Orlando, Florida, from Dec. 7-10, 2019. Explore this page to learn about the latest blood cancer research from the meeting, especially key clinical trials to advance the treatment and management of multiple myeloma
IMF brings patients that are support group leaders to ASH to share their perspective.
Dr. Brian G.M. Durie discusses key takeaways from the 2019 American Society of Hematology (ASH) annual conference for patients, caregivers, and others. Save the date: Thursday January 9, 2020, at 4:00 p.m. PT / 7:00 p.m. ET.
Patients, caregivers, and doctors around the world can view the IMF's popular livestream IMWG Conference Series, "Making Sense of Treatment" from Orlando, FL. IMF Chairman Dr. Brian G.M. Durie, Dr. Maria V. Mateos, and IMF Chief Medical Officer Dr. Joseph Mikhael distill, debate, and discuss the latest news and trends in the treatment of multiple myeloma from the 61st Annual ASH Meeting.
Watch the livestream for this year’s International Myeloma Foundation and Clinical Care Options cosponsored symposium, where an esteemed panel of international experts will offer their perspectives on practice-changing data and optimal management of patients with myeloma.
Quick 5 minute interviews from myeloma specialists at ASH on key abstracts, top 10 lists and summaries.
